期刊文献+

siRNA干扰CHRNA5基因的表达抑制尼古丁对人肺癌细胞的促增殖作用 被引量:2

siRNA interference of CHRNA5 gene expression inhibits nicotine-induced proliferation of human lung cancer cells
下载PDF
导出
摘要 目的:研究siRNA干扰尼古丁乙酰胆碱受体α5(cholinergic receptor nicotinic alpha5,CHRNA5)基因表达后对尼古丁促人肺癌A549细胞增殖作用的影响。方法:设计并合成CHRNA5-siRNA片段,并经脂质体介导转染A549细胞。荧光定量PCR、Western blotting检测转染后A549细胞中CHRNA5 mRNA和蛋白的表达,MTT法检测CHRNA5-siRNA对尼古丁促A549细胞增殖作用的影响。结果:成功构建了CHRNA5-siRNA并成功转染A549细胞。CHRNA5-siRNA转染组A549细胞的CHRNA5mRNA表达量明显低于si-NC转染对照组(0.196±0.044vs0.944±0.027,P<0.01),CHRNA5-siRNA转染组A549细胞的CHRNA5蛋白表达量明显低于si-NC转染组(0.267±0.031vs0.745±0.035,P<0.01)。在无尼古丁作用时,CHRNA5-siRNA的转染不能抑制A549细胞的增殖。在尼古丁作用下,A549细胞增殖显著增加(P<0.01),CHRNA5-siRNA转染可明显抑制尼古丁的促增殖作用(P<0.01)。结论:siRNA下调肺癌A549细胞中CHRNA5的表达可以抑制尼古丁促细胞增殖作用,CHRNA5可能是肺癌治疗的潜在靶点之一。 Objective:To study the effect of siRNA targeting CHRNA5 (cholinergic receptor nicotinic alpha 5) gene expression on nicotine-induced proliferation of lung cancer A549 cells.Methods: CHRNA5-siRNA fragment was designed and synthesized,and then transfected into A549 cells by Lipofectamine assay.Expressions of CHRNA5 mRNA and protein in transfected-A549 cells were examined by FQ-PCR and Western blotting analysis,respectively.The effect of CHRNA5-siRNA on nicotine-induced proliferation of A549 cells was detected by MTT method.Results: CHRNA5-siRNA was successfully constructed and transfected into A549 cells.CHRNA5 mRNA expression in CHRNA5-siRNA-transfected A549 cells was significantly lower than that in control si-NC control siRNA transfected A549 cells (0.196±0.044 vs 0.944±0.027,P0.01),and CHRNA5 protein expression in CHRNA5-siRNA-transfected A549 cells was also lower than that in si-NC-transfected A549 cells (0.267±0.031 vs 0.745±0.035,P0.01).When A549 cells were not treated with nicotine,CHRNA5-siRNA transfection inhibited the proliferation of A549 cells.But Nicotine increased the proliferation of A549 cells (P0.01),and this positive effect was inhibited by CHRNA5-siRNA transfection (P0.01).Conclusion: siRNA targeting CHRNA5 expression can inhibit nicotine-induced proliferation of A549 cells,which suggests that CHRNA5 may serve as a potential target for gene therapy of lung cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第6期604-608,共5页 Chinese Journal of Cancer Biotherapy
基金 中国博士后科学基金特别资助(No.200902575) 济南留学人员创业计划项目(No.20080407)~~
关键词 α5-尼古丁乙酰胆碱受体(CHRNA5) SIRNA 肺癌 尼古丁 增殖 cholinergic receptor nicotinic alpha 5(CHRNA5) small interfering RNA (siRNA) lung cancer nicotine proliferation
  • 相关文献

参考文献20

  • 1Millar NS, Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors [ J]. Neuropharmacology, 2009, 56( 1 ): 238-246.
  • 2Lain DC, Girard L, Ramirez R, Chau WS, Suen WS, Sheridan S, et al. Expression of nicotinic aeetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers [ J ]. Cancer Res, 2007, 67 (10) : 4638-4647.
  • 3Hildegard MS. Is cancer triggered by altered signaling of nicotinic acetylcholine receptors [ J ] ? Nat Rev Cancer, 2009, 9 ( 3 ) : 195- 205.
  • 4Amos CI, Wu X, Broderiek P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a suseeptibility locus for lung cancer at 15q25. 1 [J]. Nal Genet, 2008, 40 (5) : 616--622.
  • 5Hung ILl, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nico- tinic acetylcholine receptor subunit genes on 15q25 [ J]. Nature, 2008, 452(7178): 633-637.
  • 6Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease [ J ]. Nature, 2008, 452(7178) : 638-642.
  • 7lmprogo MR, Scofield MD, Tapper AR, Gardner PD. The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: Dual role in nicotine addiction and lung cancer [ J ]. Prog Neuro Biol, 2010, 92(2) : 212-26.
  • 8Improgo MR, Scofield MD, Tapper AR, Gardner PD. From smoking to lung cancer: The CHRNA5/A3/B4 connection [ J ]. Oncogene, 2010, 29(35): 4874-4884.
  • 9Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E, et al. Nicotine induces cell proliferation by β-arrestinmediated activation of Src and Rb-Raf- pathways [ J]. J Clin Invest, 2006, 116(8) : 2208-2217.
  • 10Sehuller HM. Neurotransmitter receptor mediated signaling pathways as modulators of carcinogenesis [ J]. Prog Exp Tumor Res, 2007, 39 : 45-63.

二级参考文献10

  • 1Zhao LJ, Jian H, Zhu H. Specific gene inhibition by adenovirusmediated expression of small interfering RNA [ J ]. Gene, 2003,316: 137-141.
  • 2Li WT, Zhou GY, Song XR, et al. Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference [J].Neoplasma, 2005, 2(3): 219-224.
  • 3He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses[ J]. Proc Natl Acad Sci U S A,1998, 95(5): 2509-2514.
  • 4Yuan A, Yu CJ, Luh KT, et al. Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR [ J ]. Lab Invest,2000, 80(11): 1671-1680.
  • 5Faneyte IF, Kristel PM, Maliepaard M, et al. Expression of the breast cancer resistance protein in breast cancer[ J]. Clin Cancer Res, 2002, 8(4): 1068-1074.
  • 6Burger H, Foekens JA, Look MP, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response[J]. Clin Cancer Res, 2003, 9(2): 827-836.
  • 7Harborth J, Elbashir SM, Vandenburgh K, et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing[J]. Antisense Nucleic Acid Drug Dev, 2003, 13(2): 83-105.
  • 8Liu XD, Ma SM, Liu Y, et al. Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells[ J]. Biochem Biophys Res Commun, 2004, 324(4): 1173-1178.
  • 9Zhang L, Yang N, Mohamed-Hadley A, et al. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer [ J ]. Bioohem Biophys Res Commun, 2003, 303(4): 1169-1178.
  • 10Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics[J]. Cancer Res, 2004, 64(10): 3365-3370.

共引文献1

同被引文献35

  • 1诸兰艳,陈平,蒋云生.HIF-1α和VEGF在非小细胞肺癌组织中的表达及其与肿瘤血管生成的关系[J].中国现代医学杂志,2005,15(7):1017-1019. 被引量:32
  • 2Improgo M R, Tapper A R, Gardner P D. Nicotinic ace- tylcholine receptor-mediated mechanisms in lung cancer [J]. Biochem Pharmacol, 2011, 82(8) :1015-1021.
  • 3Toumier J M, Birembaut P. Nicotinic acetylcholine recep- tors and predisposition to lung cancer[J]. Curt Opin On- col. 2011. 23(1):83-87.
  • 4Lukas R J, Changeux J P, Le Novbre N, et al. Current status of the nomenclature for nicotinic acetylcholine re- ceptors and their subunits[ J]. Pharmacol Rev, 1999, 51 (2) .397401.
  • 5Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines [J ]. Int J Cancer, 2009, 124( 1 ) :3645.
  • 6Amos C I, Wu X, Broderick P, et al. Genome-wide as- sociation scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1 [J] Nat Genet, 2008, 40 (5) .616-622.
  • 7Hung R J, McKay J D, Gaborieau V, et al. A suscepti- bility locus for lung cancer maps to nicotinic acetylcholinereceptor subunit genes on 15q25 [ J]. Nature, 2008, 452 (7187) :633-637.
  • 8Thorgeirsson T E, Geller F, Sulem P, et al. A variant as- sociated with nicotine dependence, lung cancer and pe- ripheral arterial disease [ J ]. Nature, 2008, 452 ( 7187 ) : 638-642.
  • 9Oh S H, Woo J K, Jin Q, et al. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha[ J]. Int J Cancer, 2008, 122( 1 ) :5-14.
  • 10Zhang Q, Tang X, Zhang Z F, et al. Nicotine induces hypoxia-inducible factor-lc: expression in human lung cancer cells via nicotine acethlcholine receptor-mediated signaling pathways [ J ]. Clin Cancer Res, 2007, 13 (16) :46864694.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部